BDBM300091 N-[(3R,4S)-4- hydroxytetrahydro- furan-3-yl]-2- {[(2R)-1- methoxypropan-2- yl]oxy}-6-[4-(4- methoxy-1H- pyrrolo[2,3- b]pyridin-3- yl)piperidin-1- yl]pyrimidine-4- carboxamide::US9593097, Example 472

SMILES COC[C@@H](C)Oc1nc(C(=O)N[C@@H]2COC[C@H]2O)cc(N2CCC(c3c[nH]c4nccc(OC)c34)CC2)n1

InChI Key InChIKey=UXBALOPBBHWDOF-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 300091   

TargetTyrosine-protein kinase receptor UFO(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 300091BDBM300091(N-[(3R,4S)-4- hydroxytetrahydro- furan-3-yl]-2- {[...)
Affinity DataKi:  0.0480nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
US Patent